Analysts expect Atomera to report a Q3 2026 loss of $0.12 per share on revenue of $0.1 million, with the stock currently trading near $2.87 compared to a bullish $10.00 average price target.
The primary focus for investors is the commercialization trajectory of the company's Mears Silicon Technology, particularly following the recent Joint Development Agreement with IQE plc.
This partnership aims to leverage MST to optimize RF GaN-on-silicon wafers for 5G and 6G applications, potentially accelerating the transition from engineering evaluations to high-volume royalty revenue. Additionally, management is expected to provide updates on ongoing technical evaluations for Gate-All-Around logic and 4F² DRAM transistors.